Who are V - C+V - C's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Prenatal Vitamin, Theragran Hematinic.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/v-c-v-c.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

V - C+V - C — Competitive Intelligence Brief

V - C+V - C (V - C+V - C) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin and mineral supplement. Area: Nutritional supplementation.

marketed Vitamin and mineral supplement Nutritional supplementation Small molecule Live · refreshed every 30 min

Target snapshot

V - C+V - C (V - C+V - C) — IlDong Pharmaceutical Co Ltd. V-C+V-C is a combination product containing vitamins and minerals that provides nutritional supplementation.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
V - C+V - C TARGET	V - C+V - C	IlDong Pharmaceutical Co Ltd	marketed	Vitamin and mineral supplement
Prenatal Vitamin	Prenatal Vitamin	Children's Hospital Medical Center, Cincinnati	marketed	Vitamin and mineral supplement	Maternal and fetal health
Theragran Hematinic	Theragran Hematinic	Ain Shams University	marketed	Multivitamin and mineral supplement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin and mineral supplement class)

Children's Hospital Medical Center, Cincinnati · 1 drug in this class
IlDong Pharmaceutical Co Ltd · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). V - C+V - C — Competitive Intelligence Brief. https://druglandscape.com/ci/v-c-v-c. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab